Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03376256 · ClinicalTrials.gov registry record · NA
Compuflo Instrument for Thoracic ES Identification
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03376256: Clinical Trial NA study, sponsored by University of Miami.
NCT03376256 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03376256, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate whether the Compuflo Epidural Instrument injection pump technology, which is FDA approved for lumbar epidural anesthesia, is also capable of identifying the thoracic epidural space through measurement of pressure levels. While this device is approved by the FDA for use in the procedure of the lumbar epidural, it is not used to perform the epidural procedure but rather to measure the epidural pressure. This study will likewise measure the epidural pressure.
Primary Outcome
The Compuflo Epidural Instrument measures the pressure levels in millimeters of mercury (mmHg) in the thoracic epidural space
Interventions
- DEVICE Compuflo Epidural Instrument
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-07-11 |
| Est. Completion | 2018-07-17 |
| Phase | NA |
Why NCT03376256 stopped before completion
NCT03376256 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Compuflo Epidural Instrument is the first listed.
NCT03376256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03376256 about?
NCT03376256 is a clinical study titled "Compuflo Instrument for Thoracic ES Identification". The purpose of this pilot study is to evaluate whether the Compuflo Epidural Instrument injection pump technology, which is FDA approved for lumbar epidural anesthesia, is also capable of identifying the thoracic epidural space through measurement of pressure levels. While this device is approved by...
What is the current status of trial NCT03376256?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-07-11. Estimated completion is 2018-07-17.
What interventions are being tested in trial NCT03376256?
The interventions under investigation include: Compuflo Epidural Instrument (DEVICE).
Who is sponsoring clinical trial NCT03376256?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03376256's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI